PRN Meeting: September 23, 2020 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

Atherosclerotic Cardiovascular Disease in HIV: Special Focus on Transgender and Cisgender Women

Mabel Toribio, MD, PhD

Instructor in Medicine
Massachusetts General Hospital
Boston, MA

We all know that our patients living with HIV are at higher risk for atherosclerotic cardiovascular disease.  But data on women has been lacking.  In this presentation by Mabel Toribio, you will learn to describe mechanisms of heightened atherosclerotic cardiovascular disease among people living with HIV, along with prevention and treatment strategies.  Dr. Toribio will be presenting her most current research, that includes under-represented populations – in particular, transgender and cisgender women.

Learning Objectives:

1. To describe mechanisms of heightened atherosclerotic cardiovascular disease among people living with HIV
2. To discuss prevention and treatment strategies under investigation to mitigate atherosclerotic cardiovascular disease
3. To describe specific populations, i.e. transgender and cisgender women living with HIV, that may be at high risk for cardiovascular disease

Testing for HIV and COVID-19: It Is What It Is

Bernard M. Branson, MD

Principal Consultant
Scientific Affairs LLC
Atlanta, GA

One of the greatest challenges with the COVID 19 pandemic has been the availability, speed, and accuracy of diagnostic testing.  In this presentation, Bernard Branson will discuss both HIV and COVID 19 testing.  With COVID 19, you will learn to understand the fundamentals of laboratory tests as well as appreciate the role for serology testing in identifying exposure.  As we have learned with HIV testing, it can and must get better.  In fact, with recent advances in HIV testing, it may be time for a new HIV diagnostic algorithm.  Learn which parameters affect the accuracy of tests for both COVID 19 and HIV.

Learning Objectives:

1. Understand the fundamentals of laboratory tests for COVID-19.
2. Appreciate the role for serology tests in identifying exposure to COVID-19.
3. Review new developments in HIV tests and their utility for a new diagnostic algorithm
4. Describe how similar parameters affect the accuracy of tests for COVID-19 and HIV.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. Dr. Braun (Planner/Course Director) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Mabel Toribio (Presenter) has no relevant financial relationships to disclose. Dr. Toribio will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review. Dr.Bernard M. Branson (Presenter) has no relevant financial relationships to disclose. Dr. Branson will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare